{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:47:17Z","timestamp":1790412437241,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.trre.2018.03.001","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T19:05:29Z","timestamp":1522350329000},"page":"178-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Review: Management of patients with kidney allograft failure"],"prefix":"10.1016","volume":"32","author":[{"given":"Kim L.W.","family":"Bunthof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hazzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luuk B.","family":"Hilbrands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2018.03.001_bb0005","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0010","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/S0140-6736(17)31283-7","article-title":"Strategies for long-term preservation of kidney graft function","volume":"389","author":"Wekerle","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2018.03.001_bb0015","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1034\/j.1600-6143.2002.21015.x","article-title":"Death after graft loss: an important late study endpoint in kidney transplantation","volume":"2","author":"Kaplan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0020","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000455015","article-title":"Mortality after renal allograft failure and return to dialysis","volume":"45","author":"Brar","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0025","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2018.03.001_bb0030","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1046\/j.1523-1755.2002.00640.x","article-title":"Mortality after kidney transplant failure: the impact of non-immunologic factors","volume":"62","author":"Gill","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2018.03.001_bb0035","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00007890-199702270-00011","article-title":"Diagnostic contribution of renal allograft biopsies at various intervals after transplantation","volume":"63","author":"Kon","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0040","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/TP.0b013e3181e065de","article-title":"Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure","volume":"90","author":"Gaston","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0050","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162278","article-title":"The spectrum of renal allograft failure","volume":"11","author":"Chand","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2018.03.001_bb0060","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.TP.0000151632.21551.00","article-title":"Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the \u201ccreeping creatinine\u201d study","volume":"79","author":"Dudley","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0065","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1600-6143.2004.00404.x","article-title":"Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy","volume":"4","author":"Suwelack","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0070","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1111\/j.1600-6143.2006.01535.x","article-title":"Impact of cyclosporine reduction with MMF: a randomized trial in chronic allograft dysfunction. The 'reference' study","volume":"6","author":"Frimat","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2010\/402750","article-title":"Long-term impact of cyclosporin reduction with MMF treatment in chronic allograft dysfunction: referenece study 3-year follow up","volume":"2010","author":"Frimat","year":"2010","journal-title":"J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0080","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1600-6143.2007.01745.x","article-title":"Chronic renal failure in kidney transplant recipients. Do they receive optimum care?: data from the UK renal registry","volume":"7","author":"Ansell","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0085","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1681\/ASN.V551216","article-title":"Safety and efficacy of recombinant human erythropoietin in correcting the anemia of patients with chronic renal allograft dysfunction","volume":"5","author":"Muirhead","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0090","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69086.x","article-title":"Erythropoietin and renal transplantation","volume":"69","author":"Muirhead","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.trre.2018.03.001_bb0095","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1681\/ASN.2011060546","article-title":"Correction of postkidney transplant anemia reduces progression of allograft nephropathy","volume":"23","author":"Choukroun","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0100","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/j.1600-6143.2005.00921.x","article-title":"Patient survival following renal transplant failure in Canada","volume":"5","author":"Knoll","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0105","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1093\/ndt\/gfs386","article-title":"Reduced survival and quality of life following return to dialysis after transplant failure: the Dialysis Outcomes and Practice Patterns Study","volume":"27","author":"Perl","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ki.2014.6","article-title":"Similar patient survival following kidney allograft failure compared with non-transplanted patients","volume":"86","author":"Mourad","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2018.03.001_bb0115","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1093\/ndt\/gfs004","article-title":"Estimated glomerular filtration rate at reinitiation of dialysis and mortality in failed kidney transplant recipients","volume":"27","author":"Molnar","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0120","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1093\/ndt\/gfr168","article-title":"When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study","volume":"26","author":"Tattersall","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0125","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.transproceed.2009.06.006","article-title":"Beginning hemodialysis: do patients with a failed renal transplant start in worse condition?","volume":"41","author":"Beltran","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2018.03.001_bb0130","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2215\/CJN.06640810","article-title":"Impact of dialysis modality on survival after kidney transplant failure","volume":"6","author":"Perl","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0135","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3747\/pdi.2012.00280","article-title":"Is dialysis modality a factor in the survival of patients initiating dialysis after kidney transplant failure?","volume":"33","author":"Perl","year":"2013","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.trre.2018.03.001_bb0140","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1681\/ASN.2010111155","article-title":"Hemodialysis vascular access modifies the association between dialysis modality and survival","volume":"22","author":"Perl","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0145","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/TP.0000000000000426","article-title":"Summary of the British transplantation society guidelines for management of the failing kidney transplant","volume":"98","author":"Andrews","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5527\/wjn.v4.i2.148","article-title":"Management of patients with a failed kidney transplant: dialysis reinitiation, immunosuppression weaning, and transplantectomy","volume":"4","author":"Pham","year":"2015","journal-title":"World J Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0155","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/ndt\/gfh723","article-title":"The importance of residual renal function for patients on dialysis","volume":"20","author":"Bargman","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0160","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1681\/ASN.V12102158","article-title":"Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study","volume":"12","author":"Bargman","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1053\/ajkd.2001.25198","article-title":"Residual renal function and mortality risk in hemodialysis patients","volume":"38","author":"Shemin","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.03.001_bb0170","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1053\/ajkd.2002.33927","article-title":"Continued transplant immunosuppression may prolong survival after return to peritoneal dialysis: results of a decision analysis","volume":"40","author":"Jassal","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.03.001_bb0175","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/TP.0b013e3182612921","article-title":"Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure","volume":"94","author":"Augustine","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0180","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/TP.0000000000000057","article-title":"Prolonged immunosuppression preserves nonsensitization status after kidney transplant failure","volume":"98","author":"Casey","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0185","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.humimm.2011.02.018","article-title":"Human leukocyte antigen sensitization after transplant loss: timing of antibody detection and implications for prevention","volume":"72","author":"Scornik","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.trre.2018.03.001_bb0190","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/j.ajkd.2005.04.024","article-title":"Intolerance syndrome in failed renal allografts: incidence and efficacy of percutaneous embolization","volume":"46","author":"Delgado","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.03.001_bb0195","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/01.TP.0000437558.75574.9c","article-title":"Fever, infection, and rejection after kidney transplant failure","volume":"97","author":"Woodside","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0200","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/ctr.12474","article-title":"Sensitization, pathologic, and imaging findings comparing symptomatic and quiescent failed renal allografts","volume":"28","author":"Singh","year":"2014","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2018.03.001_bb0205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1034\/j.1399-0012.2001.150606.x","article-title":"Immunosuppression should be stopped in patients with renal allograft failure","volume":"15","author":"Smak Gregoor","year":"2001","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2018.03.001_bb0210","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0215","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"Huscher","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trre.2018.03.001_bb0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/ard.2005.038638","article-title":"Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data","volume":"65","author":"Da Silva","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trre.2018.03.001_bb0225","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin cancers after organ transplantation","volume":"348","author":"Euvrard","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2018.03.001_bb0230","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/ijc.27765","article-title":"Risk of skin cancer and other malignancies in kidney, liver, heart and lung transplant recipients 1970 to 2008\u2014a Swedish population-based study","volume":"132","author":"Krynitz","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.trre.2018.03.001_bb0235","first-page":"513","article-title":"Incidence of skin cancer in 5356 patients following organ transplantation","volume":"143","author":"Lindelof","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.trre.2018.03.001_bb0240","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00007890-199003000-00006","article-title":"Incidence of skin cancer after renal transplantation in The Netherlands","volume":"49","author":"Hartevelt","year":"1990","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0245","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0190-9622(00)90154-3","article-title":"Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens","volume":"42","author":"Jensen","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.trre.2018.03.001_bb0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trre.2016.12.001","article-title":"Epstein-Barr virus and renal transplantation","volume":"31","author":"Le","year":"2017","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.trre.2018.03.001_bb0255","first-page":"59","article-title":"Kaposi's sarcoma in renal transplant recipients","volume":"10","author":"Zmonarski","year":"2005","journal-title":"Ann Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0260","doi-asserted-by":"crossref","first-page":"c570","DOI":"10.1136\/bmj.c570","article-title":"Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study","volume":"340","author":"van Leeuwen","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.trre.2018.03.001_bb0265","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/01.ju.0000080566.42381.94","article-title":"Surgical complications of graft nephrectomy in the modern transplant era","volume":"170","author":"Mazzucchi","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.trre.2018.03.001_bb0270","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/01.ju.0000050658.94353.24","article-title":"Cumulative incidence, indications, morbidity and mortality of transplant nephrectomy and the most appropriate time for graft removal: only nonfunctioning transplants that cause intractable complications should be excised","volume":"169","author":"Secin","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.trre.2018.03.001_bb0275","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/j.1600-6143.2007.01884.x","article-title":"Nephrectomy after transplant failure: current practice and outcomes","volume":"7","author":"Johnston","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0280","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1681\/ASN.2009050480","article-title":"Transplant nephrectomy improves survival following a failed renal allograft","volume":"21","author":"Ayus","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0285","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5500\/wjt.v1.i1.4","article-title":"Transplant nephrectomy","volume":"1","author":"Akoh","year":"2011","journal-title":"World J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0290","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ctr.12654","article-title":"Allograft nephrectomy versus no-allograft nephrectomy for renal transplantation: a meta-analysis","volume":"30","author":"Wang","year":"2015","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2018.03.001_bb0295","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1046\/j.1523-1755.2002.00373.x","article-title":"Opportunities to improve the care of patients with kidney transplant failure","volume":"61","author":"Gill","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2018.03.001_bb0300","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1097\/01.ASN.0000137879.97445.6E","article-title":"Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and erythropoietin resistance","volume":"15","author":"Lopez-Gomez","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0305","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/17.suppl_8.29","article-title":"C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients","volume":"17","author":"Wanner","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0310","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0022-5347(17)35105-4","article-title":"Transplant nephrectomy over 20 years: factors involved in associated morbidity and mortality","volume":"151","author":"O'Sullivan","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.trre.2018.03.001_bb0315","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/tri.12927","article-title":"Renal graft intolerance syndrome in late graft failure patients: efficacy and safety of embolization as first line treatment compared to surgical removal","volume":"30","author":"Al Badaai","year":"2017","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2018.03.001_bb0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00007890-199201000-00009","article-title":"The influence of nephrectomy of the primary allograft on retransplant graft outcome in the cyclosporine era","volume":"53","author":"Sumrani","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0325","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00007890-199507270-00005","article-title":"Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy","volume":"60","author":"Abouljoud","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0330","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/j.1523-1755.2005.00343.x","article-title":"The effect of a first kidney transplant on a subsequent transplant outcome: an experimental and clinical study","volume":"67","author":"Lair","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2018.03.001_bb0335","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/ndt\/gfn567","article-title":"Does nephrectomy of failed allograft influence graft survival after re-transplantation?","volume":"24","author":"Ahmad","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0340","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1432-2277.2010.01197.x","article-title":"Impact of failed allograft nephrectomy on initial function and graft survival after kidney retransplantation","volume":"24","author":"Schleicher","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2018.03.001_bb0345","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11255-012-0369-8","article-title":"Impact of renal graft nephrectomy on second kidney transplant survival","volume":"45","author":"Surga","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0350","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.transproceed.2014.05.029","article-title":"Kidney retransplantation: removal or persistence of the previous failed allograft?","volume":"46","author":"Dinis","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2018.03.001_bb0355","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5500\/wjt.v4.i2.141","article-title":"Impact of transplant nephrectomy on peak PRA levels and outcome after kidney re-transplantation","volume":"4","author":"Tittelbach-Helmrich","year":"2014","journal-title":"World J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0360","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/iju.12455","article-title":"Impact of graft nephrectomy on outcomes of second kidney transplantation","volume":"21","author":"Fadli","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.trre.2018.03.001_bb0365","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.transproceed.2016.09.016","article-title":"Graft survival in patients who received second allograft, comparing those with or without previous failed allograft nephrectomy","volume":"48","author":"Sanchez-Gonzalez","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2018.03.001_bb0370","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.2215\/CJN.00260112","article-title":"Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy","volume":"7","author":"Del Bello","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0375","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/ndt\/gfw041","article-title":"Dynamics and epitope specificity of anti-human leukocyte antibodies following renal allograft nephrectomy","volume":"31","author":"Lachmann","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0380","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.TP.0000078895.24606.45","article-title":"Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy","volume":"76","author":"Martin","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0385","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.trim.2007.01.001","article-title":"Distribution of donor-specific antibodies in the cortex and the medulla of renal transplants with chronic allograft nephropathy","volume":"17","author":"Bocrie","year":"2007","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trre.2018.03.001_bb0390","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ajt.13958","article-title":"Allelic and epitopic characterization of intra-kidney allograft anti-HLA antibodies at allograft nephrectomy","volume":"17","author":"Milongo","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0395","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0272-6386(12)80934-6","article-title":"Ablation of irreversibly rejected renal allograft by embolization with absolute ethanol: a new clinical application","volume":"22","author":"Lorenzo","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.03.001_bb0400","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0041-1345(03)00624-9","article-title":"Transvascular ethanol embolization: first option for the management of symptomatic nonfunctioning renal allografts left in situ","volume":"35","author":"Delgado","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2018.03.001_bb0405","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1432-2277.2002.tb00145.x","article-title":"Percutaneous renal artery embolisation of non-functioning renal allografts with clinical intolerance","volume":"15","author":"Cofan","year":"2002","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2018.03.001_bb0410","first-page":"422","article-title":"Embolization of non-functioning renal allograft: efficacy and control of systemic inflammation","volume":"25","author":"Perez Martinez","year":"2005","journal-title":"Nefrologia"},{"key":"10.1016\/j.trre.2018.03.001_bb0415","first-page":"99","article-title":"Ablation of non functioning renal allograft by embolization: a valid alternative to graft nephrectomy?","volume":"77","author":"Solinas","year":"2005","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.trre.2018.03.001_bb0420","series-title":"Eurotransplant annual report","author":"Branger","year":"2015"},{"key":"10.1016\/j.trre.2018.03.001_bb0425","series-title":"US national data report on kidney transplants","year":"2017"},{"key":"10.1016\/j.trre.2018.03.001_bb0430","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/01.tp.0000235434.13327.11","article-title":"Evaluating the survival benefit of kidney retransplantation","volume":"82","author":"Rao","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0435","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1600-6143.2007.01786.x","article-title":"Repeat organ transplantation in the United States, 1996\u20132005","volume":"7","author":"Magee","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0440","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0041-1345(00)02379-4","article-title":"Time to first graft loss as a risk factor for second renal allograft loss","volume":"33","author":"Arndorfer","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2018.03.001_bb0445","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/ajt.12690","article-title":"Risk factors for retransplant kidney recipients: relisting and outcomes from patients' primary transplant","volume":"14","author":"Heaphy","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0450","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/ctr.12722","article-title":"Re-transplants compared to primary kidney transplants recipients: a mate kidney paired analysis of the OPTN\/UNOS database","volume":"30","author":"Khalil","year":"2016","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2018.03.001_bb0455","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.transproceed.2015.09.003","article-title":"Pre-emptive retransplantation in patients with chronic kidney graft failure","volume":"47","author":"Florit","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2018.03.001_bb0460","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/ndt\/gfk061","article-title":"The role of pre-emptive re-transplant in graft and recipient outcome","volume":"21","author":"Goldfarb-Rumyantzev","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0465","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1097\/TP.0000000000000953","article-title":"Waiting time between failure of first graft and second kidney transplant and graft and patient survival","volume":"100","author":"Wong","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0470","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/TP.0b013e31827a938f","article-title":"Risks and benefits of preemptive second kidney transplantation","volume":"95","author":"Johnston","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0475","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5414\/CN108849","article-title":"The clinical outcomes of second kidney transplantation in IgA nephropathy: a multicenter retrospective study","volume":"86","author":"Baek","year":"2016","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0480","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.transproceed.2017.03.063","article-title":"Long-term clinical outcomes of first and second kidney transplantation in patients with biopsy-proven IgA nephropathy","volume":"49","author":"Kim","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2018.03.001_bb0485","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1097\/00007890-199706150-00016","article-title":"Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: analysis of the incidence, risk factors, and impact on graft survival","volume":"63","author":"Andresdottir","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0490","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/TP.0000000000000200","article-title":"Atypical hemolytic uremic syndrome recurrence after kidney transplantation","volume":"98","author":"Matar","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0495","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2017.06.024","article-title":"Living donor kidney transplantation in atypical hemolytic uremic syndrome: a case series","volume":"70","author":"Duineveld","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2018.03.001_bb0500","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1097\/TP.0000000000001909","article-title":"Midterm outcomes of 12 renal transplant recipients treated with eculizumab to prevent atypical hemolytic syndrome recurrence","volume":"101","author":"Levi","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0505","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1681\/ASN.2015060626","article-title":"Re-examining risk of repeated HLA mismatch in kidney transplantation","volume":"27","author":"Tinckam","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0510","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/ajt.14495","article-title":"The impact of repeated mismatches in kidney transplantations performed after non-renal solid organ transplantation","volume":"18","author":"Cote","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0515","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1600-6143.2010.03083.x","article-title":"Retransplantation after BK virus nephropathy in prior kidney transplant: an OPTN database analysis","volume":"10","author":"Dharnidharka","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0520","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/TP.0b013e31822d08c1","article-title":"Results of repeat renal transplantation after graft loss from BK virus nephropathy","volume":"92","author":"Geetha","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0525","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1432-2277.2007.00620.x","article-title":"Kidney retransplantation following graft loss to polyoma virus-associated nephropathy: an effective treatment option in simultaneous pancreas and kidney transplant recipients","volume":"21","author":"Mindlova","year":"2008","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2018.03.001_bb0530","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.TP.0000156165.83160.09","article-title":"Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations","volume":"79","author":"Hirsch","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0535","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ajt.12110","article-title":"BK polyomavirus in solid organ transplantation","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0540","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s40620-015-0200-6","article-title":"Kidney retransplantation for BK virus nephropathy with active viremia without allograft nephrectomy","volume":"28","author":"Huang","year":"2015","journal-title":"J Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0545","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-6143.2005.01137.x","article-title":"Preemptive retransplantation for BK virus nephropathy: successful outcome despite active viremia","volume":"6","author":"Womer","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0550","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-6143.2005.01171.x","article-title":"Retransplantation after polyomavirus-associated nephropathy: just do it?","volume":"6","author":"Hirsch","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0555","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/j.1600-6143.2006.01543.x","article-title":"Retransplantation after post-transplant lymphoproliferative disorders: an OPTN\/UNOS database analysis","volume":"6","author":"Johnson","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0560","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ctr.12659","article-title":"Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder","volume":"30","author":"Rouphael","year":"2016","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2018.03.001_bb0565","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/j.1600-6143.2004.00562.x","article-title":"Successful renal retransplantation after post-transplant lymphoproliferative disease","volume":"4","author":"Karras","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0570","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2215\/CJN.03790417","article-title":"A French Cohort Study of kidney retransplantation after post-transplant lymphoproliferative disorders","volume":"12","author":"Caillard","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2018.03.001_bb0575","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1111\/ajt.13369","article-title":"Kidney retransplantation in the ipsilateral iliac fossa: a surgical challenge","volume":"15","author":"Ooms","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2018.03.001_bb0580","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/01.tp.0000203559.57088.f6","article-title":"Surgical aspects of third and subsequent renal transplants performed by the extraperitoneal access","volume":"81","author":"Mazzucchi","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2018.03.001_bb0585","doi-asserted-by":"crossref","first-page":"S280","DOI":"10.1177\/089686080102103S49","article-title":"Peritoneal dialysis in the patient with a failing renal allograft","volume":"21","author":"Davies","year":"2001","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.trre.2018.03.001_bb0590","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/ndt\/gfl010","article-title":"Comparison of peritoneal dialysis and haemodialysis after renal transplant failure","volume":"21","author":"de Jonge","year":"2006","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X18300120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X18300120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T12:06:53Z","timestamp":1660738013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X18300120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0955470X18300120"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2018.03.001","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review: Management of patients with kidney allograft failure","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2018.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}